A clinical trial of NOX-A12 in patients with mutiple myeloma who have previously been treated and who will be receiving bortezomib and dexamethasone treatment.
- Registry ID
- EUCTR2011-004651-40
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- NOXXON Pharma AG
- Start date
- 2012-03-05
- Completion date
- 2015-09-30
- Last update
- 2026-08-16
Conditions
- Relapsed multiple myeloma
Summary
To assess the safety and tolerability of NOX-A12 alone (pilot group only) and in combination with VD
To determine the overall response rate according to IMWG uniform response criteria (ORR = best response at least partial response(PR))
Locations
- , , Austria
- , , Germany
- , , Italy
View on source registry